Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 9/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5038360 | 0.91 | KCNA5 (0.48) | KCNA5KCNH2CYP3A4CYP2C19GRM2 | |
| SCHEMBL5033715 | 0.90 | KCNA5 (0.50) | KCNA5KCNH2CYP3A4CYP2C19GRM2 | |
| SCHEMBL884639 | 0.87 | KCNA5 (0.45) | KCNA5KCNH2CYP3A4GRM2CYP11B1 | |
| SCHEMBL5032466 | 0.87 | KCNA5 (0.45) | KCNA5KCNH2GRM2CYP11B1CYP11B2 | |
| SCHEMBL884569 | 0.87 | KCNA5 (0.51) | KCNA5KCNH2GRM2CYP11B1CYP11B2 | |
| SCHEMBL884449 | 0.85 | KCNA5 (0.44) | KCNA5KCNH2CYP3A4GRM2ALDH1A1 | |
| SCHEMBL884595 | 0.83 | KCNA5 (0.45) | KCNA5KCNH2GRM2CYP11B1CYP11B2 | |
| SCHEMBL2063132 | 0.82 | KCNA5 (0.80) | KCNA5KCNH2FFAR1HRH3 | |
| SCHEMBL5030913 | 0.81 | KCNA5 (0.51) | KCNA5KCNH2CYP11B1CYP11B2 | |
| SCHEMBL884457 | 0.81 | KCNA5 (0.51) | KCNA5KCNH2CYP3A4CYP2C19CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1940406-A2 | POTASSIUM CHANNEL INHIBITORS | Merck and Co., Inc. (US) | 2008-07-09 | — | — | EP | claimed |
| WO-2007050348-A2 | POTASSIUM CHANNEL INHIBITORS | MERCK & CO., INC. (US) | 2007-05-03 | — | — | WO | claimed |